Skip to content

aTyr Pharma ATYR Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-105.3%-25.8pp-107.8%-28.1pp-103.2%-25.3pp-85.2%-23.5pp-79.5%-24.0pp
Return on assets-79.2%-18.9pp-78.1%-19.2pp-75.8%-16.9pp-64.2%-15.7pp-60.3%-17.1pp
Return on invested capital-105.9%-27.2pp-109.2%-22.6pp-101.5%-22.6pp-87.5%-24.9pp-78.6%-18.9pp
Liquidity
Current ratio5.8×-2.0×5.3×-0.2×5.9×+0.5×5.6×-2.0×7.8×+1.7×
Quick ratio5.8×-2.0×5.3×-0.2×5.9×+0.5×5.6×-2.0×7.8×+1.7×
Cash ratio0.9×-0.1×0.7×0.0×0.4×-0.4×1.1×+0.5×+0.5×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×-0.1×0.2×0.0×0.2×0.0×
Debt-to-assets0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$0.59-31.9%$0.73-23.0%$0.83-4.2%$0.83-26.4%$0.87-32.1%
Valuation
Market capitalization$54.88M-88.2%
Enterprise value$57.17M
Price / book0.9×
Free cash flow yield-108.1%
Earnings yield-127.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do aTyr Pharma's ratios come from?
Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.